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Abstract
Corneal diseases such as keratoconus represent a relatively common disorder in the
human population. However, treatment is restricted to corneal transplantation, which only
occurs in the most advanced cases. Cell based therapies may offer an alternative approach
given that the eye is amenable to such treatments and corneal diseases like keratoconus
have been associated specifically with the death of corneal keratocytes. The ability to gen-
erate corneal keratocytes in vitro may enable a cell-based therapy to treat patients with ker-
atoconus. Human induced pluripotent stem cells (hiPSCs) offer an abundant supply of cells
from which any cell in the body can be derived. In the present study, hiPSCs were success-
fully differentiated into neural crest cells (NCCs), the embryonic precursor to keratocytes,
and then cultured on cadaveric corneal tissue to promote keratocyte differentiation. The
hiPSC-derived NCCs were found to migrate into the corneal stroma where they acquired a
keratocyte-like morphology and an expression profile similar to corneal keratocytes in vivo.
These results indicate that hiPSCs can be used to generate corneal keratocytes in vitro and
lay the foundation for using these cells in cornea cell-based therapies.
Introduction
The cornea represents the transparent anterior-most portion of the eye. It acts to protect the
underlying iris, pupil and anterior chamber as well as providing two-thirds of the refractive
power of the eye. A healthy cornea has a central thickness of about 490 to 620 μm, 90% of
which consists of the stromal layer. The corneal stroma is composed of highly organised colla-
gen fibrils which arrange into lamellae that run parallel to the corneal surface [1]. The corneal
stroma is populated by a small number of non-myelinated nerve bundles and trafficking
immune cells, but its main cellular occupant is the corneal keratocyte.
Corneal keratocytes are derived from neural crest cells (NCCs). During embryogenesis,
NCCs occupy the presumptive cornea at around E10.5 in mice and subsequently differentiate
into keratocytes, causing thickening of the stroma [2, 3]. Keratocytes are quiescent,
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mesenchymal-like cells which extend out keratopodia that contact neighbouring keratocytes,
forming a continuously linked cell population within the stroma [4]. Keratocan and Lumican
are important keratan sulphate-containing proteoglycans that are highly expressed in corneal
keratocytes [5] and regulate transparency of the cornea by organising and maintaining the
topography of collagen fibrils so as to minimise ocular opacity [6]. When this function is per-
turbed, corneal health and transparency is affected [7]. In patients suffering from keratoconus,
there is a reduction in the number of corneal keratocytes in the stroma due to apoptosis [8].
This loss, together with reduced thickness of the stroma, leads to ectasia that is characterised
by a conical cornea due to its thinning and protrusion [9–11]. In patients with advanced kera-
toconus, corneal scarringmay also be present [12]. Corneal scarring is associatedwith activated
keratocytes responding to a pathological environment, and their conversion to myofibroblasts
that deposit non-transparent fibrotic tissue [13]. The definitive treatment available to patients
with advanced keratoconus is corneal transplantation, a procedure that depends on donor tis-
sue availability and may be complicated by immunological rejection and graft failure.
Given the pathophysiology of keratoconus is believed to mainly be associated with loss of
corneal keratocytes, it remains possible that alternative, cell-based therapies could be adopted
to reduce dependency on donor tissue. The discovery that adult somatic cells retain the ability
to be reprogrammed into pluripotent cells [14, 15] has provided a limitless resource of stem
cells from which any cell type in the body can be attained. Human induced Pluripotent Stem
Cells (hiPSCs) have been used to generate many cell types, such as retinal pigment epithelium
[16, 17], which is currently being utilised in clinical trials for autologous transplant into
patients with age-related macular degeneration [18]. The use of hiPSCs is ethically less prob-
lematic than human embryonic stem cells and hiPSCs can be generated from the patient,
reprogrammed into another cell type and used for autologous transplantation, reducing the
risk of immunological rejection.
This study establishes an in vitro protocol for differentiating hiPSCs into cells with a corneal
keratocyte-like phenotype. hiPSCs were first differentiated into NCCs before being introduced
to two different downstream culturingmethods. In the first method, hiPSC-derivedNCCs
were cultured in 3D and a keratocyte-like fate was adopted, these cells expressed and deposited
Keratocan. However, qPCR analysis of these cells suggested they were dissimilar to in vivo cor-
neal keratocytes. In the secondmethod, hiPSC-derivedNCCs were exposed to cadaveric cor-
neal tissue where they actively migrated between the stromal collagen fibrils and showed
morphological as well as transcriptional similarity to corneal keratocytes in vivo.
Materials and Methods
Tissue Culture
Tissue samples and cell lines were prepared and used in accordance with Health and Disability
Ethics Committee approvals assigned by the Ministry of Health New Zealand (ref# NTX/07/
08/080/AM04). All cultures were grown in a 37°C, 5% CO2 humidified incubator. hiPSCs were
grown on Geltrex (ThermoFisher) in Modified Tennelle’s Special Recipe 1 (MTESR1, StemCell
Technologies). All cells were dissociated and passaged to a new well/ plate or into a single cell
suspension using Accutase (StemCell Technologies). The iPSC line used was generated using
modifiedRNAs encoding the Yamanaka factors and was first describedby Warren et al, (2010)
[19].
NCC production
We followed the protocols outlined in Chambers et al (2013), and Lee et al (2010) [19, 20]. To
begin, a confluent 10 cm cell culture dish was passaged to Geltrex coated 6-well plates (NCCs
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were not grown on mitomycin treated mouse embryonic fibroblasts). The number of cells was
estimated using a haemocytometer and transferred to a 6-well plate at a concentration of 10,
000–20, 000 cells/ cm2. 10 μM Y-27632 was used in the media for the first 24 hours after pas-
saging only. Due to growth, cells were split 1:2 once during each protocol, typically between
day 6 and day 8, using Accutase (StemCell Technologies). Upon completion of NCC deriva-
tion, cells were frozen back for storage in liquid nitrogen (in 10% DMSO/ 90% BSA) or used
for downstream applications. We repeated this protocol a total of eleven times on different pas-
sages of the iPSCs and consistently yielded>80% NCC conversion.
3D culturing
The cells of one well of a 6-well plate (~2 x 105 cells) were dissociated and made into a single-
cell suspension in a 15 ml Falcon tube using Accutase. These cells were then pelleted at 700 g
for 5 mins. The media was aspirated and carefully replaced with Keratocyte Differentiation
Media (Advanced DMEM (Life Technologies), 10 ng/ml FGF2, 0.1 mM ascorbic acid-2-phos-
phate). Pelleted cells were left to grow for 21 days with media changes every second day.
Limbal rim assay
Corneo-scleral Limbal rims were freeze thawed (20 mins at -80°C, 20 mins in a 37°C water
bath x10) to degrade any endogenous protein epitopes. Rims were cut into slices using a scalpel
and each slice was placed in one well of a 12-well plate. 1.5 ml of KDMwas added to each well.
hiPSC-derivedNCCs were dissociated from one well of a 6-well plate and placed in a 15 ml Fal-
con tube. Cells were then pelleted at 700g for 5 minutes. Media was aspirated from the 15 ml
Falcon tube and the cells were re-suspended in 8 ml of KDM. Cell number was determined
using a haemocytometer and ~2 x 105 cells were seeded directly onto the sclera region of each
limbal rim slice using a Hamilton syringe.We seeded cells on the sclera as we found the conical
shape of the cornea caused the unattached cells to accumulate at the region of the limbal rim.
The following day, live/ dead cell staining was performed using LIVE/DEADViability/Cyto-
toxicity Kit for mammalian cells (Molecular Probes), to detect if cells had appropriately
attached to the rim.
Cryosectioning
3D cultured NCCs or limbal rim slices seededwith NCCs were washed twice in PBS and fixed
in 4% PFA overnight at 4°C. The tissues were washed twice in PBS and then placed in 1% low
melting point agarose containing 5% sucrose and 0.9% agar (made up in water) in cryomoulds.
After one hour the cryoblockswere removed from the cryomoulds and placed in 30% Sucrose/
PBS. Cryoblockswere incubated overnight at 4°C then 30% Sucrose/PBS was replaced and left
for another night at 4°C. Cryoblockswere flash frozen on dry ice and stored at -80°C prior to
sectioning. 14 μm transverse sections were cut in a cryostat machine (set to -25°C) and trans-
ferred to a gelatine-coatedmicroscope slide.
Immunohistochemistry
Slides containing cryosectionswere dried overnight at 4°C and then washed twice in Tris Buff-
ered Saline containing 0.1% Triton X100 (TBST). Slides were then placed in block solution (3%
BSA, 5% Goat serum in TBST) for at least one hour. The primary antibody was then applied in
the same block solution (all at 1:100) and left overnight at 4°C; SOX2 (R&D Systems,
MAB2018), AP2a (DSHB, 3B5), p75NTR (Advanced Targeting Systems, AB-N07) Keratocan
(SantaCruz, SC-66941), HNK1 (SigmaAldrich, C6680), Vimentin (Abcam, ab92547) and
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ABCB5 (SigmaAldrich,HPA026975) were used. Slides were washed 4 x 15 mins in TBST and
incubated in secondary antibody (Abcam, 96901 and 96883) at 1:500 in TBST for 2 hours at
room temperature. Slides were then washed twice with TBST and mounted under a coverslip
with Prolong Gold (ThermoFisher).
Quantitative Real-Time PCR
Cultures of hiPSCs and NCCs in 6-well plates were washed twice in PBS and then exposed to 1
ml of Trizol for 10 mins. Trizol extracted RNA was then transferred to a 1.5 ml eppendorff
tube and stored at -80°C. 3D-cultured NCCs and limbal rim slices were similarly treated with 1
ml of Trizol and transferred to a flat-bottomed 2 ml eppendorff tube. The tissue was then
homogenised and stored at -80°C. RNA was purified from Trizol using a PureLinkTM RNA
Mini Kit (Ambion) and cDNA was prepared using a PrimeScriptTM RT Master Mix (Takara).
Each reaction of real-time PCR used 8 μl of a master mix containing SYBR1 Premix Ex Taq
(Tli RnaseH Plus), ROX plus (Takara) and 10 μM primer mix, and 2 μl of diluted cDNA. Prim-
ers for SYBR assays were synthesized using the Harvard PrimerBank as a reference. All amplifi-
cations were performed in triplicate, withHPRT1 used for normalization of RNA content. A
negative control with no cDNA was also used in each qPCR. Relative expression was deter-
mined using the comparative CT method (2-ΔΔCT).
Results
Differentiation of hiPSCs into NCCs
As corneal keratocytes are derived from cephalic NCCs during embryogenesis [2, 3] it was rea-
soned that a 2-step protocol could be developedwhereby hiPSCs were first induced to differenti-
ate into NCCs, of which a number of protocols have been developed [20–25], and then matured
into keratocytes in the second step. Two establishedNCC protocols (Chambers et al, (2013) and
Lee et al, (2010)) were performed and were compared for which workedmost efficiently based
on a number of variables; the percentage of NCCsmade, the levels of NCC genes expressed, the
degree of reduction in pluripotent marker gene expression, and the cell morphology observed. It
was found that the protocol describedby Chambers et al (2013) workedmost efficiently, produc-
ing cells with a NCC-like dendriticmorphology, loss of SOX2-positive immunostaining and a
high percentage (>80%) of cells labelledwith the cephalic NCCmarkers AP2a and p75NTR (Fig
1 and S1 Fig). Quantitative PCR (qPCR) analysis showed that the Chambers et al (2013) protocol
performed better at yielding higher expression levels of neural crest genes (such as PAX3, SOX9,
SOX10, ZIC1, and TFAP2A) than the Lee et al (2010) protocol (S2 Fig). As a result, the Chambers
et al (2013) protocol was used for further study and protocol development.
Extensive qPCR analysis of NCC and pluripotency gene markers was undertaken to confirm
the NCC identity of the hiPSC-derivedNCCs. All neural crest markers tested were more highly
expressed in the hiPSC-derivedNCCs than in hiPSCs (Fig 2). In particular, PAX3, SOX10,
ZIC1,MSX2 and TFAP2A were>100-fold more highly expressed in the hiPSC-derivedNCC
population than in hiPSCs. The pluripotency genes SOX2,OCT3/4 and NANOGwere all
reduced by at least 10-fold in hiPSC-derivedNCCs compared to hiPSCs (Fig 2). KLF4 expres-
sion did persist at a relatively unchanged level, which is consistent with KLF4 being highly
expressed in NCCs [26] and their derivatives (such as smooth muscle cells [27]), and with
KLF4 being the most highly expressed transcription factor in the mouse cornea [28]. In addi-
tion to analysing gene expression, we also undertook protein analysis (Fig 3A). We performed
antibody labelling for HNK1, AP2a and Vimentin to test for NCCmarkers. All hiPSC-derived
NCCs were positive for Vimentin and AP2a, and approximately 20% were positive for HNK1
(Fig 3A). These results, in addition to cell morphology observations, loss of SOX2 antibody
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staining and AP2a+ and p27NTR+ staining, support a conclusion whereby NCCs were success-
fully derived from hiPSCs.
Culturing hiPSC-derived NCCs in 3D produces a corneal keratocyte
phenotype
For the second step of our 2-step protocol, hiPSC-derivedNCCs were further differentiated
into cells with a keratocyte-like phenotype. Given that the corneal keratocyte exists within a
Fig 1. Generation of Neural Crest Cells (NCCs) from human induced Pluripotent Stem Cells (hiPSCs). (A) hiPSC
colonies were observable at day 0 of a 12-day protocol for Neural Crest Cells (NCCs) derivation. On day 9, cells were more
mesenchymal in appearance and possessed a typical NCC-like dendritic morphology. (B)(C) We observed hiPSCs were
SOX2+, but hiPSC derived NCCs were SOX2-. >80% of derived NCCs were positive for neural crest markers AP2a and
p27NTR. Brightfield scale bar represents 200 μm, low magnification (10X) confocal images scale bar represents 100 μm,
high magnification (63X) confocal images scale bar represents 10 μm.
doi:10.1371/journal.pone.0165464.g001
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collagenousmatrix in the cornea stroma, we hypothesized that culturingNCCs in a 3D matrix
may promote their conversion to a corneal keratocyte-like cell. To do this, a cell suspension of
hiPSC-derivedNCCs was pelleted and then cultured in a defined keratocyte differentiation
media (see schematic in Fig 3 and ref [29]). After 21 days, this 3D culture had grown and did
not dissociate upon agitation. These aggregates were fixed and cryo-sectionedfor analysis by
immuno-staining. Labelling for HNK1 and AP2a showed these markers were reduced after
3D-culture but for small patches of AP2a-positive staining (Fig 3B). Vimentin labelling per-
sisted after 3D-culture, which is consistent with this protein being a label of corneal keratocytes
as well as NCCs (Fig 3B). Keratocan and ABCB5 are specificmarkers of corneal keratocytes
and were not detectable by protein analysis in hiPSC-derivedNCCs (Fig 3A). Strikingly, all
cells in the 3D-culture were positive for Keratocan and extracellularly deposited Keratocan
could be observed (Fig 3B). ABCB5 staining was detected in approximately 30% of 3D-cultured
cells (Fig 3B). These results suggest that hiPSC-derivedNCCs cultured in 3D lose their neural
crest identity and convert to a corneal keratocyte-like cell type.
To better analyse the potential fate change of the hiPSC-derivedNCCs to a corneal kerato-
cyte phenotype, we performed extensive qPCR analysis on the 3D-cultures. Relative to hiPSC-
derivedNCCs, there was a general down-regulation of NCC genes after the 3D-culture. PAX3,
SOX10,CX32, FOXD3 andMSX1, and to a lesser extent TFAP2A, SNAIL, ID2 andMSX2 had
reduced levels of gene expression in 3D-cultured NCCs relative to hiPSC-derivedNCCs (Fig
4A). A few neural crest genes increased their levels of expression when cultured in 3D, such as
ZIC1 and SLUG, but most of the assayed neural crest genes had reduced expression in hiPSC-
derivedNCCs cultured in 3D for 21 days (Fig 4A). Analysis of genes that are highly expressed
in corneal keratocytes showed their expression levels increase after 3D-culture (Fig 4A). In par-
ticular, BMP3, CDH5, B3GnT7, PtDGS,AQP1 and KLF4were>10-fold more highly expressed
Fig 2. Expression analysis of derived NCCs compared to hiPSCs. Quantitative polymerase chain reaction (qPCR)
analysis showed derived NCCs had higher expression of many neural crest markers relative to hiPSCs. The pluripotency
markers SOX2, OCT3/4 and NANOG were significantly reduced in NCCs, but KLF4 expression was maintained at a
similar level.
doi:10.1371/journal.pone.0165464.g002
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Fig 3. 3D culturing promotes a corneal keratocyte-like cell fate. (A) Panels show hiPSC-derived NCCs
stained for HNK1, Vimentin, AP2a, Keratocan (shown in red as it was co-stained with the AP2a panel) and
ABCB5. (B) 3D cultures were generated as shown in the schematic at the top of the Figure. Panels show
transverse cryosections of the 3D cultured NCCs stained for HNK1, Vimentin, AP2a, Keratocan (red) and
ABCB5. Arrows in the Keratocan+ panel indicates extracellular deposits of Keratocan. Scale bar represents
100 μm.
doi:10.1371/journal.pone.0165464.g003
Fig 4. Expression analysis of 3D-cultured NCCs compared to non 3D-cultured NCCs and cadaveric human
corneal keratocytes. (A) qPCR analysis showed 3D cultured derived NCCs had lower levels of expression of many
neural crest markers, such as PAX3, SOX10, CX32, FOXD3 and MSX1, compared to non-3D cultured NCCs. Genes
that are highly expressed in corneal keratocytes were up-regulated by 3D culture. (B) The gene expression profile of
3D-cultured NCCs was largely incompatible with cadaveric corneal keratocytes. Most genes assayed had significantly
higher or lower levels of gene expression when the two populations were compared.
doi:10.1371/journal.pone.0165464.g004
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after 3D culturing (Fig 4A). ALDH1A1,ALDH3A1,KERATOCAN and CHST6 were also
increased. These results suggest that 3D culture of NCCs promotes conversion of these cells
towards a keratocyte-like fate.
Subsequently, these in vitro derived corneal keratocyte-like cells were compared to in vivo
human corneal keratocytes obtained from cadaveric corneas. RNA acquired from corneal but-
tons, stripped of their endothelial and epithelial layers, leaving only the stromal layer of the cor-
nea, was used as a source of corneal keratocytes. qPCR analysis showed keratocytemarkers
ALDH3A1,KERATOCAN, PtDGS,AQP1 and KLF4were expressed at much lower levels in
3D-culturedNCCs compared to human corneal keratocytes (Fig 4B). However, other corneal
keratocytemarkers were expressed at similar levels in both cell populations, including
ALDH1A1, BMP3, B3GnT7 and CHST6 (Fig 4B). Neural crest genes ZIC1, SLUG andMSX2
were more highly expressed in 3D-cultured NCCs relative to human corneal keratocytes
whereas SNAIL, FOXD3 andMSX1were more lowly expressed (Fig 4B). Despite this, a number
of genes were expressed at similar levels in 3D-cultured NCCs relative to human corneal kera-
tocytes, including PAX3, SOX10 and ZIC5 (Fig 4B).
In conclusion, the 3D culture of hiPSC-derivedNCCs promotes both the expression of cor-
neal keratocyte-specificgenes and also the deposition of Keratocan in extracellularmatrix sug-
gesting that these cells can be induced to adopt a keratocyte fate in vitro.
Culturing hiPSC-derived NCCs on limbal rims promotes keratocyte-like
fate
Having demonstrated that a 3D-culture environment can induce keratocyte differentiation, it
was next examined whether native corneal tissue would be more effective at inducing a kerato-
cyte phenotype. To achieve this aim, hiPSC-derivedNCCs were exposed to cadaveric corneal
tissue. This technique used a donated, cadaveric, peripheral corneo-scleral rim (see Fig 5A),
which was put through ten freeze-thaw cycles to deplete the cornea of endogenous proteins.
Interestingly, before freeze-thaw cycling was performed, the limbal rims contained cells posi-
tive for AP2a and Keratocan (S3 Fig). AP2a is a marker of cephalic neural crest cells, therefore
this result suggests corneal keratocytes still retain a marker of neural crest identity even in
adult tissue.
To test if exposure to corneal tissue promoted conversion to a keratocyte-like fate, we seeded
hiPSC-derivedNCCs onto the sclera of a corneal rim slice (Fig 5A). These cells attached to the
corneal slice and calcein AM live-cell staining showed they were still alive by day 4 (see S4 Fig
for the dead cell stain) and had migrated to the corneal region of the rim (Fig 5B). Calcein AM
imaging also showed that these cells displayed a NCC-likemorphology and their movement
towards the cornea indicated an intrinsic migratory capacity (Fig 5B). At day 7, NCCs on the
surface of the cornea could no longer be observed (Fig 5B). Ethidium staining for dead cells
showed no positive labelling (data not shown), but higher magnifications of the CalceinAM
live cell stain revealed that the NCCs had migrated into the stroma (Fig 5B). In transverse sec-
tions performed on day 5 after seeding, derivedNCCs can be observedon top of the cornea
and at the lateral edges where these cells appear to be migrating into the stroma between the
collagen fibrils (S5A Fig). Sectioning through the sclera region of the rim showed now cells
reside within this region of the tissue (S5B Fig). Taken together, our results suggest that derived
NCCsmigrate over the sclera to the corneal region of the rim, where they then migrate round
the dissected lateral edges and into the exposed collagen fibrils.
We next wished to observe if hiPSC-derivedNCCs cultured on limbal rims acquire a corneal
keratocyte-like identity. In transverse sections of control non-seeded corneal rim slices no
DAPI, AP2a or Keratocan staining was observed, indicating successful depletion of any
Derivation of Corneal Keratocytes from Human iPSCs
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endogenous signal (Fig 6A, top panels). DAPI stained nuclei in cells positive for AP2a and Ker-
atocan were observed in limbal rims seededwith hiPSC-derivedNCCs (Fig 6A, bottom panels).
Higher magnification showed that these cells had migrated in-between the collagen fibrils that
constitute the corneal stroma (Fig 6B) and had a similar morphology to human corneal
Fig 5. hiPSC derived NCCs seeded onto limbal rims migrate to the cornea and then migrate into the stroma.
(A) hiPSC-derived NCCs were seeded onto the scleral region of limbal rim slices as shown in the schematic. (B)
After 4 days, live cell staining with Calcein AM indicated all derived NCCs had migrated to the corneal surface region
of the limbal rim slice. By day 7 derived NCCs had migrated into the stroma of the cornea. Scale bars for low
magnification images (let hand side) represent 200 μm and for higher magnification images (right hand side)
represent 100 μm.
doi:10.1371/journal.pone.0165464.g005
Derivation of Corneal Keratocytes from Human iPSCs
PLOS ONE | DOI:10.1371/journal.pone.0165464 October 28, 2016 10 / 17
Fig 6. Limbal rim seeded NCCs adopt a corneal keratocyte-like fate and migrate between the collagen lamellae. (A)
Control non-seeded rim cryosections showed no DAPI+ nuclei or AP2a+/ Keratocan+ cells. Limbal rims seeded with derived
NCCs did contain AP2a+/ Keratocan+ cells after 21 days of culture (arrows). (B) High magnification images show Keratocan+
derived NCCs migrated within the collagen lamellae of the stromal layer of the cornea (this panel is a higher magnification of
the Keratocan staining shown in (A). ABCB5+, Vimentin+ and HNK1+ staining was also detected in these cells. Scale bars in
(A) represent 100 μm, scale bars in (B) represent 50 μm.
doi:10.1371/journal.pone.0165464.g006
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keratocytes found in vivo (see S3 Fig and [30]). In addition to Keratocan and AP2a staining, we
also observed iPSC-derivedNCCs seeded on to corneal rims were positively labelled with
ABCB5, Vimentin and HNK1 (Fig 6B). These results suggest that seeding of hiPSC-derived
NCCs onto corneal rims promotes expression of corneal keratocytemarkers, such as Vimentin,
Keratocan and ABCB5, but also maintains NCC-specificmarker labelling (HNK1 and AP2a).
qPCR analysis of hiPSC-derivedNCCs cultured on limbal rim slices for 21 days showed
NCCmarkers such as PAX3, ZIC1, SOX10, SNAIL, TWIST, ZIC5, FOXD3,MSX1 andMSX2
were similar to levels of expression found in human corneal keratocytes (Fig 7). Only TFAP2A,
CX32, P75NTR and ID2 had levels of expression that were disproportionately higher in the
rim-culturedNCCs relative to human corneal keratocytes (Fig 7). Levels of expression for
many keratocytemarkers were also similar between these two cell populations, especially
ALDH1A1, BMP3, B3GnT7, CHST6, PtDGS,AQP1 and KLF4 (Fig 7). ALDH3A1 and KERA-
TOCANwere less highly expressed in hiPSC-derivedNCCs cultured on limbal rims than in
endogenous corneal keratocytes, and CDH5 was more highly expressed (Fig 7). Despite these
exceptions, the overall gene expression profile of rim-culturedNCCs was more similar than
3D-culturedNCCs to in vivo corneal keratocytes (Fig 7).
Taken together, our findings demonstrate that a two-step protocol involving the conversion
of hiPSCs to NCCs using the Chambers et al (2013) protocol followed by culture on limbal
rims is sufficient to induce formation of keratocyte-like cells in vitro.
Discussion
In this study, we have shown hiPSC-derivedNCCs adopt corneal keratocyte-like characteristics
when cultured in three dimensions or seeded onto cadaveric corneal tissue. Of these two cul-
ture methods, we found seeding hiPSC-derivedNCCs onto cadaveric human limbal rims was
Fig 7. Expression analysis shows limbal rim seeded NCCs adopt an expression profile that is similar to human
corneal keratocytes. qPCR analysis indicated hiPSC-derived NCCs cultured on limbal rim slices (blue bars) adopted
an expression profile that was more analogous to human corneal keratocytes than hiPSC-derived NCCs grown in 3D
cultures (red bars). Importantly, the expression of a number of keratocyte markers was much higher when derived
NCCs were cultured on limbal rim slices, such as ALDH3A1, KERATOCAN, PtGDS and AQP1.
doi:10.1371/journal.pone.0165464.g007
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most successful, with these cells adopting a similar morphology and molecularmarker profile
to native corneal keratocytes after just 21 days of culture.
Other stem cell sources have been utilised for differentiating corneal keratocyte-like cells
[31–34], but our study represents the first attempt to generate corneal keratocytes from hiPSCs.
A recent report used a similar approach as we present here, by first converting H1 hESCs to
NCCs, and then further differentiating these cells in 3D cultures to corneal keratocytes [35].
We believe our protocol is more amenable to downstream applications (including translation
to human therapies) as we use a feeder-free system to culture hiPSCs and generate NCCs,
whereas the protocol describedby Hertsenberg and Funderburgh (2016) uses the PA6 mouse
embryonic fibroblast line as feeder cells [35]. In addition, we find seeding corneo-scleral limbal
rims with hiPSC-derivedNCCs better simulates the in vivo environment corneal keratocytes
inhabit, and greatly improved the conversion of derivedNCCs to a corneal keratocyte-like
fate compared to 3D cultures. NCCs seeded onto limbal rims expressed markers such as
KERATOCAN, PTGDS,AQP1 and KLF4 at between 10- and 100-fold higher levels compared
to 3D-cultured NCCs.ALDH3A1, which encodes an aldehyde dehydrogenase important in
maintaining the transparency of the corneal stroma [36], was expressed 1000-fold higher in
NCCs seeded to limbal rims compared to NCCs cultured in 3D. These differences in expression
levels between 3D-cultured and corneal rim seeded hiPSC-derivedNCCs are important as they
highlight that limbal rim seeded cells are more comparable to native human corneal kerato-
cytes. Our results therefore support a model whereby direct seeding of NCCs to cadaveric cor-
neal tissue effectively promotes corneal keratocyte differentiation. This likely indicates that the
corneal stroma contains keratocyte differentiation stimuli despite the removal of endogenous
cells. It also suggests that the use of NCCs as a cell-based therapy to repopulate corneal tissue
may be a viable clinical option for corneal dystrophies such as keratoconus and should be
explored further.
Our study concentrated on looking at the endpoint of NCC differentiation. Follow up stud-
ies may benefit from understanding how derivedNCCs progressively differentiate into kerato-
cytes and if methods can be modified to improve this process. During embryogenesis,NCC
migration and differentiation is closely linked to the extracellularmatrix [37]. In vitro studies
have shown the diameter of matrix fibres acts as a guidance cue and can define neuronal and
neural crest differentiation [38, 39]. Given the corneo-scleral rims used here offer a matrix that
corneal keratocytes occupy in vivo, it is possible that their topographical makeup (such as ori-
entation and diameter of the collagen fibrils) better enables the acquisition of a corneal kerato-
cyte-like fate in our derivedNCCs.
Our antibody staining for AP2a showed native corneal keratocytes still express this marker
of cranial neural crest, suggesting they retain some level of neural crest fate even in adulthood.
Whilst it is difficult to ascertain the developmental time point to which our NCCs correspond
relative to in vivo embryogenesis, we did find that cells positive for Keratocan are observed
after just 21 days. These results support previous findings that corneal keratocytes maintain a
level of fate plasticity that is closely matched to the stem cell-like characteristics of NCCs [40].
Thus, our approach of primarily derivingNCCs and then exposing these cells to corneal tissue
represents a simple pathway for corneal keratocyte differentiation. Future studies will deter-
mine if hiPSC-derivedNCCs transplanted into live corneal tissue can aid in recovery from
injury or disease. For any clinical or tissue engineering application, it is important to ensure
that the cells can be used safely. Whilst we have not analysed cell proliferation in the current
study, we did observe extensive proliferation of hiPSCs cultured on limbal rims (data not
shown). This same rate of division was not observedwhen hiPSC-derivedNCCs were seeded
onto limbal rims, suggesting these cells have a lower proliferative capacity.
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In summary, we have established a novel protocol for converting hiPSCs to keratocyte cells.
These cells may be of use in future clinical applications, such as cell-based therapies that could
treat causes of corneal blindness, such as inherited corneal dystrophies and keratoconus.
Supporting Information
S1 Fig. Characterisationof the successful derivation of NCCs from hiPSCs.AP2a antibody
staining showed the NCC derivation protocol used here converted a high percentage of cells to
a NCC fate. Scale bar represents 100 μm.
(TIF)
S2 Fig. Comparison between Lee et al (2010) protocol and Chambers et al (2013) protocol
for NCC derivation from hiPSCs. Expression of NCC genes PAX3, SOX9, SOX10 and ZIC1
were significantly higher in the Chambers et al (2013) protocol compared to the Lee et al
(2010) protocol in our hands.
(TIF)
S3 Fig. Non-seededand non-freeze-thawedhuman corneas contain Keratocan+ and AP2a+
keratocytes.Donated cadaveric human cornea cryosections showed endogenous corneal kera-
tocytes can be labelled with antibodies for Keratocan and AP2a. Scale bar represents 100 μm.
(TIF)
S4 Fig. Live/Dead cell viability staining showsmost limbal rim seededderivedNCCs are
viable. Ethidium staining to label dead cells showed minimal cell death at day 4 in cells seeded
to limbal rim slices. Scale bar for top panels indicates 200 μm, scale bar for bottom panel indi-
cates 100 μm.
(TIF)
S5 Fig. Sectioning through the sclera shows no cells reside in this region of a seededrim
and derivedNCCs likelymigrate around the edge of the cornea (A) Transverse section of
cornea stained for DAPI after 7 days of culture with derived NCCs. Arrows indicate the posi-
tion of derived NCCs on top of the cornea and at the lateral edges where they appear to be
entering the collagen fibrils of the stroma. (B) Transverse section view of DAPI (left panel) and
ABCB5 (right panel) stained sclera after 21 days of culture with derivedNCCs. No cells were
observed in any region of the sclera.
(TIF)
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